We Bleed Too™

Innovative Hematology

Women can be uncomfortable asking others—even their healthcare providers—about their personal health. In the We Bleed Too™ podcast series, a hematologist, gynecologist, and registered nurse openly discuss key topics related to reproductive health and bleeding disorders including menstruation, reproductive wellness, hormonal balance, and more throughout the different stages of a woman’s life.

  1. Pregnancy with a Bleeding or Clotting Disorder

    May 25

    Pregnancy with a Bleeding or Clotting Disorder

    In this episode of We Bleed Too™, we delve into the complexities of pregnancy for individuals with blood disorders. © Innovative Hematology, Inc. 2026 ----- About Innovative Hematology: Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. As a certified medical home recognized for excellence in comprehensive patient-centered health care, IHI is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), Indiana’s only and one of the nation’s top federally recognized hemophilia treatment centers. We treat hemophilia, von Willebrand disease, HHT and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as nutritional anemias. Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research. Learn more at ⁠www.innovativehematology.org⁠ Podcast Sponsor and Disclosures This podcast is sponsored by Innovative Hematology, Inc. (IHI), who may have direct or indirect financial relationships with some of the organizations, products, or companies discussed. The opinions and views expressed by guests are their own and do not necessarily reflect the opinions or views of the podcast, our host[s], or IHI. Episode-specific disclosures National Bleeding Disorders Foundation (NBDF): IHI has a longstanding partnership with NBDF. Learn more at: https://www.innovativehematology.org/partnerships/. Medical and Scientific Advisory Council (MASAC) isa part of NBDF and is composed of physicians, scientists and other medical professionals with a wide range of expertise on bleeding disorders, blood safety and infectious disease. Dr. Magdalena Lewandowska serves on this council. Innovative Hematology has no financial interest in these products or relationships with the manufacturers: Pitocin, Aspirin, Door Dash Medical Disclaimer The We Bleed Too™ podcast (sponsored by Innovative Hematology, Inc.) is for general informational and educational purposes only and does not constitute the practice of medicine, nursing, or any other professional health care service. The information included in the podcast does not constitute medical advice and no doctor/patient relationship is formed by watching this podcast. Please consult your physician for personalized medical advice and do not disregard or delay obtaining medical advice for any medical condition you may have based on the content of this podcast. The use of information or products on this podcast or materials linked from this podcast does not create any recommendation or endorsement of any specific test, procedure, treatment, or product. While we strive for accuracy, medicine is constantly evolving, and information provided may not reflect the most current medical developments. We make no warranties about the completeness or accuracy of the information or statements made on the We Bleed Too™ podcast or by any podcast guests and we have no duty to correct or update the content of the podcast to resolve or clarify any inconsistent or outdated information that may be included in the podcast. To the maximum extent permitted by law, the We Bleed Too™ podcast and its sponsor, host(s), guest(s), and affiliated entities shall not be liable for any direct, indirect, incidental, special, or consequential damages arising from your use of or reliance on information provided. Any reliance on information provided through the podcast is solely at the listener’s own risk. If you think you are having a medical emergency, please contact your healthcare provider or call 911 immediately. Further, any third-party materials or content of any third-party site referenced in this podcast do not necessarily reflect the opinions of We Bleed Too™ or Innovative Hematology, Inc. Statements made on the podcast have not been evaluated by the Food and Drug Administration.

    28 min
  2. Heavy Bleeding: How to control it, why seek care

    May 25

    Heavy Bleeding: How to control it, why seek care

    Join the We Bleed Too™, we explore the complexities of women's health, focusing on heavy menstrual bleeding and the often-overlooked underlying causes. © Innovative Hematology, Inc. 2026 ----- About Innovative Hematology: Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. As a certified medical home recognized for excellence in comprehensive patient-centered health care, IHI is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), Indiana’s only and one of the nation’s top federally recognized hemophilia treatment centers. We treat hemophilia, von Willebrand disease, HHT and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as nutritional anemias. Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research. Learn more at ⁠www.innovativehematology.org⁠ Podcast Sponsor and Disclosures This podcast is sponsored by Innovative Hematology, Inc. (IHI), who may have direct or indirect financial relationships with some of the organizations, products, or companies discussed. The opinions and views expressed by guests are their own and do not necessarily reflect the opinions or views of the podcast, our host[s], or IHI. Episode-specific disclosures National Bleeding Disorders Foundation (NBDF): IHI has a longstanding partnership with NBDF. Learn more at: https://www.innovativehematology.org/partnerships/. Foundation for Women & Girls+ with Blood Disorders (FWGBD): IHTC is recognized as a leader in the specialized care of women and girls with blood disorders following the WGBD™ Clinic of Excellence Model. Learn more at https://www.innovativehematology.org/center-of-excellence/ Medical Disclaimer The We Bleed Too™ podcast (sponsored by Innovative Hematology, Inc.) is for general informational and educational purposes only and does not constitute the practice of medicine, nursing, or any other professional health care service. The information included in the podcast does not constitute medical advice and no doctor/patient relationship is formed by watching this podcast. Please consult your physician for personalized medical advice and do not disregard or delay obtaining medical advice for any medical condition you may have based on the content of this podcast. The use of information or products on this podcast or materials linked from this podcast does not create any recommendation or endorsement of any specific test, procedure, treatment, or product. While we strive for accuracy, medicine is constantly evolving, and information provided may not reflect the most current medical developments. We make no warranties about the completeness or accuracy of the information or statements made on the We Bleed Too™ podcast or by any podcast guests and we have no duty to correct or update the content of the podcast to resolve or clarify any inconsistent or outdated information that may be included in the podcast. To the maximum extent permitted by law, the We Bleed Too™ podcast and its sponsor, host(s), guest(s), and affiliated entities shall not be liable for any direct, indirect, incidental, special, or consequential damages arising from your use of or reliance on information provided. Any reliance on information provided through the podcast is solely at the listener’s own risk. If you think you are having a medical emergency, please contact your healthcare provider or call 911 immediately. Further, any third-party materials or content of any third-party site referenced in this podcast do not necessarily reflect the opinions of We Bleed Too™ or Innovative Hematology, Inc. Statements made on the podcast have not been evaluated by the Food and Drug Administration.

    21 min
  3. Are IUDs Safe? The types, myths, and realities

    May 25

    Are IUDs Safe? The types, myths, and realities

    In this episode of We Bleed Too™, we dive into the myths and facts surrounding IUDs, exploring their history, functionality, and safety. © Innovative Hematology, Inc. 2026 -------------- Innovative Hematology’s GO+ Clinic for Women & Girls: ⁠www.innovativehematology.org/go-clinic ⁠ About Innovative Hematology: Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. As a certified medical home recognized for excellence in comprehensive patient-centered health care, IHI is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), Indiana’s only and one of the nation’s top federally recognized hemophilia treatment centers. We treat hemophilia, von Willebrand disease, HHT and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as nutritional anemias. Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research. Learn more at ⁠www.innovativehematology.org ⁠ Podcast Sponsor and Disclosures This podcast is sponsored by Innovative Hematology, Inc. (IHI), who may have direct or indirect financial relationships with some of the organizations, products, or companies discussed. The opinions and views expressed by guests are their own and do not necessarily reflect the opinions or views of the podcast, our host[s], or IHI. Episode-specific disclosures National Bleeding Disorders Foundation (NBDF): IHI has a longstanding partnership with NBDF. Learn more at: https://www.innovativehematology.org/partnerships/. Innovative Hematology has no financial interest in these products or relationships with the manufacturers: Mirena, Kyleena, Skyla, Paragard, Cytotec, Misoprostol, Celebrex, Celecoxib, Aleve, Ibuprofen Medical Disclaimer The We Bleed Too™ podcast (sponsored by Innovative Hematology, Inc.) is for general informational and educational purposes only and does not constitute the practice of medicine, nursing, or any other professional health care service. The information included in the podcast does not constitute medical advice and no doctor/patient relationship is formed by watching this podcast. Please consult your physician for personalized medical advice and do not disregard or delay obtaining medical advice for any medical condition you may have based on the content of this podcast. The use of information or products on this podcast or materials linked from this podcast does not create any recommendation or endorsement of any specific test, procedure, treatment, or product. While we strive for accuracy, medicine is constantly evolving, and information provided may not reflect the most current medical developments. We make no warranties about the completeness or accuracy of the information or statements made on the We Bleed Too™ podcast or by any podcast guests and we have no duty to correct or update the content of the podcast to resolve or clarify any inconsistent or outdated information that may be included in the podcast. To the maximum extent permitted by law, the We Bleed Too™ podcast and its sponsor, host(s), guest(s), and affiliated entities shall not be liable for any direct, indirect, incidental, special, or consequential damages arising from your use of or reliance on information provided. Any reliance on information provided through the podcast is solely at the listener’s own risk. If you think you are having a medical emergency, please contact your healthcare provider or call 911 immediately. Further, any third-party materials or content of any third-party site referenced in this podcast do not necessarily reflect the opinions of We Bleed Too™ or Innovative Hematology, Inc. Statements made on the podcast have not been evaluated by the Food and Drug Administration.

    23 min
  4. Get More Iron: Oral vs. IV Iron, Supplements, Foods

    May 25

    Get More Iron: Oral vs. IV Iron, Supplements, Foods

    In this episode of We Bleed Too™, we explore the complexities of iron deficiency and anemia. Discover the challenges of treating iron deficiency with diet alone, the nuances of oral versus IV iron supplementation, and the importance of monitoring iron levels. © Innovative Hematology, Inc. 2026 -------------- Innovative Hematology’s GO+ Clinic for Women & Girls: ⁠www.innovativehematology.org/go-clinic ⁠ About Innovative Hematology: Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. As a certified medical home recognized for excellence in comprehensive patient-centered health care, IHI is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), Indiana’s only and one of the nation’s top federally recognized hemophilia treatment centers. We treat hemophilia, von Willebrand disease, HHT and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as nutritional anemias. Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research. Learn more at ⁠www.innovativehematology.org⁠ Podcast Sponsor and Disclosures This podcast is sponsored by Innovative Hematology, Inc. (IHI), who may have direct or indirect financial relationships with some of the organizations, products, or companies discussed. The opinions and views expressed by guests are their own and do not necessarily reflect the opinions or views of the podcast, our host[s], or IHI. Episode-specific disclosures National Bleeding Disorders Foundation (NBDF): IHI has a longstanding partnership with NBDF. Learn more at: https://www.innovativehematology.org/partnerships/. Innovative Hematology has no financial interest in these products or relationships with the manufacturers: Benadryl Medical Disclaimer The We Bleed Too™ podcast (sponsored by Innovative Hematology, Inc.) is for general informational and educational purposes only and does not constitute the practice of medicine, nursing, or any other professional health care service. The information included in the podcast does not constitute medical advice and no doctor/patient relationship is formed by watching this podcast. Please consult your physician for personalized medical advice and do not disregard or delay obtaining medical advice for any medical condition you may have based on the content of this podcast. The use of information or products on this podcast or materials linked from this podcast does not create any recommendation or endorsement of any specific test, procedure, treatment, or product. While we strive for accuracy, medicine is constantly evolving, and information provided may not reflect the most current medical developments. We make no warranties about the completeness or accuracy of the information or statements made on the We Bleed Too™ podcast or by any podcast guests and we have no duty to correct or update the content of the podcast to resolve or clarify any inconsistent or outdated information that may be included in the podcast. To the maximum extent permitted by law, the We Bleed Too™ podcast and its sponsor, host(s), guest(s), and affiliated entities shall not be liable for any direct, indirect, incidental, special, or consequential damages arising from your use of or reliance on information provided. Any reliance on information provided through the podcast is solely at the listener’s own risk. If you think you are having a medical emergency, please contact your healthcare provider or call 911 immediately. Further, any third-party materials or content of any third-party site referenced in this podcast do not necessarily reflect the opinions of We Bleed Too™ or Innovative Hematology, Inc. Statements made on the podcast have not been evaluated by the Food and Drug Administration.

    19 min
  5. Iron Deficiency: Signs, Symptoms, Misconceptions

    May 25

    Iron Deficiency: Signs, Symptoms, Misconceptions

    In this episode of We Bleed Too™, we dive into the often-overlooked topic of iron deficiency and its impact on women's health. © Innovative Hematology, Inc. 2026 ----- About Innovative Hematology: Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. As a certified medical home recognized for excellence in comprehensive patient-centered health care, IHI is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), Indiana’s only and one of the nation’s top federally recognized hemophilia treatment centers. We treat hemophilia, von Willebrand disease, HHT and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as nutritional anemias. Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research. Learn more at ⁠www.innovativehematology.org ⁠ Podcast Sponsor and Disclosures This podcast is sponsored by Innovative Hematology, Inc. (IHI), who may have direct or indirect financial relationships with some of the organizations, products, or companies discussed. The opinions and views expressed by guests are their own and do not necessarily reflect the opinions or views of the podcast, our host[s], or IHI. Episode-specific disclosures National Bleeding Disorders Foundation (NBDF): IHI has a longstanding partnership with NBDF. Learn more at: https://www.innovativehematology.org/partnerships/. Medical and Scientific Advisory Council (MASAC) isa part of NBDF and is composed of physicians, scientists and other medical professionals with a wide range of expertise on bleeding disorders, blood safety and infectious disease. Dr. Magdalena Lewandowska serves on this council. Innovative Hematology has no financial interest in these products or relationships with the manufacturers: Benadryl Medical Disclaimer The We Bleed Too™ podcast (sponsored by Innovative Hematology, Inc.) is for general informational and educational purposes only and does not constitute the practice of medicine, nursing, or any other professional health care service. The information included in the podcast does not constitute medical advice and no doctor/patient relationship is formed by watching this podcast. Please consult your physician for personalized medical advice and do not disregard or delay obtaining medical advice for any medical condition you may have based on the content of this podcast. The use of information or products on this podcast or materials linked from this podcast does not create any recommendation or endorsement of any specific test, procedure, treatment, or product. While we strive for accuracy, medicine is constantly evolving, and information provided may not reflect the most current medical developments. We make no warranties about the completeness or accuracy of the information or statements made on the We Bleed Too™ podcast or by any podcast guests and we have no duty to correct or update the content of the podcast to resolve or clarify any inconsistent or outdated information that may be included in the podcast. To the maximum extent permitted by law, the We Bleed Too™ podcast and its sponsor, host(s), guest(s), and affiliated entities shall not be liable for any direct, indirect, incidental, special, or consequential damages arising from your use of or reliance on information provided. Any reliance on information provided through the podcast is solely at the listener’s own risk. If you think you are having a medical emergency, please contact your healthcare provider or call 911 immediately. Further, any third-party materials or content of any third-party site referenced in this podcast do not necessarily reflect the opinions of We Bleed Too™ or Innovative Hematology, Inc. Statements made on the podcast have not been evaluated by the Food and Drug Administration.

    13 min
  6. Bleeding and Gender Bias: What are my options? What should I ask?

    May 25

    Bleeding and Gender Bias: What are my options? What should I ask?

    In this episode of We Bleed Too™, we explore the challenges women face in being believed about their health and the misconceptions surrounding bleeding disorders. © Innovative Hematology, Inc. 2026 ---- Are you at risk for a bleeding disorder? National Bleeding Disorder Foundation: ⁠https://www.betteryouknow.org/ ⁠ About Innovative Hematology: Innovative Hematology, Inc. treats blood disorders—from common to rare—every day. As a certified medical home recognized for excellence in comprehensive patient-centered health care, IHI is home to the Indiana Hemophilia and Thrombosis Center (also known as the IHTC, a 501(c)3), Indiana’s only and one of the nation’s top federally recognized hemophilia treatment centers. We treat hemophilia, von Willebrand disease, HHT and other rare bleeding and clotting conditions. Innovative Hematology also treats sickle cell disease, thalassemia, and other blood disorders such as nutritional anemias. Innovative Hematology is both nationally and internationally distinguished as a Center of Excellence for its leadership in blood disorder patient care, education and research. Learn more at ⁠www.innovativehematology.org⁠ Podcast Sponsor and Disclosures This podcast is sponsored by Innovative Hematology, Inc. (IHI), who may have direct or indirect financial relationships with some of the organizations, products, or companies discussed. The opinions and views expressed by guests are their own and do not necessarily reflect the opinions or views of the podcast, our host[s], or IHI. Episode-specific disclosures National Bleeding Disorders Foundation (NBDF): IHI has a longstanding partnership with NBDF. Learn more at: https://www.innovativehematology.org/partnerships/. Innovative Hematology has no formal relationship with Let’s Talk Period Innovative Hematology has no financial interest in these products or relationships with the manufacturers: Advil, Aleve, Ibuprofen, Naproxen, Aspirin, Tylenol, Celebrex, Celecoxib, Medical Disclaimer The We Bleed Too™ podcast (sponsored by Innovative Hematology, Inc.) is for general informational and educational purposes only and does not constitute the practice of medicine, nursing, or any other professional health care service. The information included in the podcast does not constitute medical advice and no doctor/patient relationship is formed by watching this podcast. Please consult your physician for personalized medical advice and do not disregard or delay obtaining medical advice for any medical condition you may have based on the content of this podcast. The use of information or products on this podcast or materials linked from this podcast does not create any recommendation or endorsement of any specific test, procedure, treatment, or product. While we strive for accuracy, medicine is constantly evolving, and information provided may not reflect the most current medical developments. We make no warranties about the completeness or accuracy of the information or statements made on the We Bleed Too™ podcast or by any podcast guests and we have no duty to correct or update the content of the podcast to resolve or clarify any inconsistent or outdated information that may be included in the podcast. To the maximum extent permitted by law, the We Bleed Too™ podcast and its sponsor, host(s), guest(s), and affiliated entities shall not be liable for any direct, indirect, incidental, special, or consequential damages arising from your use of or reliance on information provided. Any reliance on information provided through the podcast is solely at the listener’s own risk. If you think you are having a medical emergency, please contact your healthcare provider or call 911 immediately. Further, any third-party materials or content of any third-party site referenced in this podcast do not necessarily reflect the opinions of We Bleed Too™ or Innovative Hematology, Inc. Statements made on the podcast have not been evaluated by the Food and Drug Administration.

    12 min

About

Women can be uncomfortable asking others—even their healthcare providers—about their personal health. In the We Bleed Too™ podcast series, a hematologist, gynecologist, and registered nurse openly discuss key topics related to reproductive health and bleeding disorders including menstruation, reproductive wellness, hormonal balance, and more throughout the different stages of a woman’s life.